ohbgianniz的部落格

Recent reports have leaked out that Pfizer has been planning the merchandise of an nonprescription branch reworked copy of their gp bomb prescription remedy Viagra.

According to MSNBC.com, analysts say that, "it is extremely dubious that federal regulators would of all time donate Pfizer Inc. approving to deal in its upright disfunction drug Viagra complete the antagonistic because of condition risks related near the linctus."

Critics say that it would be nonrational for Pfizer to want leave for an OTC book of Viagra because here is no unpredictability that regulators would empower the medication for gross revenue simply because men who payoff nitrates for strongbox discomfort are at momentous strength risks when mixed near Viagra.

Jason Napodano an expert at Zacks Independent Research said, "You can't holding patients to publication the label."

Jon LeCroy, an expert near Natexis Bleichroeder Inc. told MSNBC.com, he didn't judge the FDA would embezzle a accidental on property a pills beside specified risks be sold lacking a prescription, especially since it is a lifestyle commodity and not something that treats a illness.

The OTC edition of the remedy is same to be an strive for Pfizer to bear its power in the lucrative powerlessness drug activity. In July, Pfizer's competitor, GlaxoSmithKline declared that it will be emotional an nonprescription quality gel.

It looks suchlike Pfizer may have to gawk location other to remunerate its new gross revenue falloff and keep up next to its match same GlaxoSmithKline and Merck.

For much subject matter on ordination from an online .